Michael Grimley, MD, Pediatric Hematology & Oncology, Cincinnati, OH, Cincinnati Children's Hospital Medical Center

MichaelGrimleyMD

Pediatric Hematology & Oncology Cincinnati, OH

Pediatric Hematologic Oncology

Professor of Clinical Pediatrics

Dr. Grimley is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Grimley's full profile

Already have an account?

Education & Training

  • Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 1996 - 1999
  • San Antonio Uniformed Services Health Education Consortium
    San Antonio Uniformed Services Health Education ConsortiumResidency, Pediatrics, 1992 - 1995
  • Emory University School of Medicine
    Emory University School of MedicineClass of 1992
  • University of Illinois at Urbana-ChampaignB.S., Biochemistry, 1988

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2002 - 2012
  • OH State Medical License
    OH State Medical License 1996 - 2023
  • PA State Medical License
    PA State Medical License 1995 - 1996
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • 1st Runner-up, Howard H. Johnson Jr Award Uniformed Services Pediatric Seminar, 2000
  • Recipient of Air Force Health Professions Scholarship 1988

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Refined diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a prospective study in children and young adults  
    Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, Myers K, Grimley M, Bleesing J, El-Bietar J, Wallace G, Chima RS, Paff Z, Laskin BL, Blood, 1/29/2014
  • Secondary Hemophagocytic Lymphohistiocytosis (HLH) from a Presumed Brown Recluse Spider Bite  
    Dandoy C, Grimley M, J Clin Immunol, 1/16/2014
  • The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients  
    Khandelwal P1, Lawrence J, Filipovich AH, Davies SM, Bleesing JJ, Jordan MB, Mehta P, Jodele S, Grimley MS, Kumar A, Myers K, Marsh RA, Pediatr Transplant, 1/1/2014
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • The Schedule and Dose of Alemtuzumab Determine the Incidence of Mixed Chimerism in Pediatric Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoieti...
    Marsh RA, Kim MO. Liu C, Bellman D, Hart L, Jordan MB, Bleesing JJ, Mehta PA, Jodele S, Myers KC, Kumar A, Grimley M, Davies SM, Filipovich AH, Biology of Blood and Marrow Transplantation; Tandem BMT Annual Meeting, Salt Lake City, UT, 1/1/2013
  • Engraftment Syndrome Has Distinct Biology Compared with Graft Versus Host Disease.
    Khandelwal P, Mellor-Heinke S, Davies SM, Grimley M, Bleesing J, Jordan M, Jodele S, Marsh R, Mehta P, Myers KC, Rehman N, Smiley K, Villanueva J, Filipovich AH, Biology of Blood and Marrow Transplantation; Tandem BMT Annual Meeting, Salt Lake City, UT, 1/1/2013
  • Immune Reconstitution Following Reduced Intensity Stem Cell Transplant for Non-malignant Disorders.
    Bednarski, JJ, Le C, Murray L, Hayashi R, Yu L, Dalal J, Kamani N, Jacobsohn D, Pulsipher M, Petrovic A, Chan KW, Grimley M, Haut P, Adams R, Douglas D, Chaudhury S, G..., Biology of Blood and Marrow Transplantation; Tandem BMT Annual Meeting, Salt Lake City, UT, 1/1/2013
  • Join now to see all

Lectures

  • Department of Pediatric Grand Rounds: "Hematopoietic Stem Cell Therapy for Sickle cell Disease: Current Practice and Emerging Trends" 
    University of Kentucky Children's Hospital, Lexington, KY - 1/1/2013
  • "Bone Marrow Transplant for Inherited Bone Marrow Failure Syndromes and Primary Immunodeficiencies" 
    1/1/2013
  • "Bone Marrow Transplant for Sickle Cell Disease: Current Practice and Emerging Trends" 
    1/1/2013
  • Join now to see all

Other

  • Diamond-Blackfan Anemia. 
    Shelton JB, Neuhauser TN, Grimley MS, Diamond-Blackfan Syndrome, Check Sample

Press Mentions

  • Chimerix’s Brincidofovir Diarrhoea Concerns Won’t Affect Phase II Study
    Chimerix’s Brincidofovir Diarrhoea Concerns Won’t Affect Phase II StudyDecember 18th, 2018

Hospital Affiliations